Back
Tekla Healthcare Opportunities Fund Vs. iShares US Pharmaceuticals ETF Industry Stock Comparison
Sell
37
THQ
Tekla Healthcare Opportunities Fund
Last Price:
20.80
Seasonality Move:
2.98%
Sell
24
IHE
iShares US Pharmaceuticals ETF
Last Price:
68.31
Seasonality Move:
4.68%
Sell
37
Tekla Healthcare Opportunities Fund (THQ)
is a Sell
Is Tekla Healthcare Opportunities Fund a Buy, Sell or Hold?
- The current Tekla Healthcare Opportunities Fund [THQ] share price is $21.01. The Score for THQ is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- THQ is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
24
iShares US Pharmaceuticals ETF (IHE)
is a Sell
Is iShares US Pharmaceuticals ETF a Buy, Sell or Hold?
- The current iShares US Pharmaceuticals ETF [IHE] share price is $68.34. The Score for IHE is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
- IHE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
THQ Stock Price Chart
What is Tekla Healthcare Opportunities Fund's stock price today?
-
The Tekla Healthcare Opportunities Fund share price today is $21.01
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and THQ is experiencing selling pressure, which indicates risk of future bearish movement.
IHE Stock Price Chart
What is iShares US Pharmaceuticals ETF's stock price today?
-
The iShares US Pharmaceuticals ETF share price today is $68.34
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IHE is experiencing selling pressure, which indicates risk of future bearish movement.
THQ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.22 | Sell |
| Relative Strength Index (14 RSI): | 33.13 | Sell |
| Chaikin Money Flow: | 22445 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
IHE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.48 | Sell |
| Relative Strength Index (14 RSI): | 31.77 | Sell |
| Chaikin Money Flow: | -18727 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
THQ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.3 | Sell |
| 20-day SMA: | 21.82 | Sell |
| 50-day SMA: | 21.8 | Sell |
| 200-day SMA: | 20.48 | Buy |
| 8-day EMA: | 21.29 | Sell |
| 20-day EMA: | 21.61 | Sell |
| 50-day EMA: | 21.65 | Sell |
| 200-day EMA: | 20.62 | Buy |
IHE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 69.55 | Sell |
| 20-day SMA: | 70.45 | Sell |
| 50-day SMA: | 70.96 | Sell |
| 200-day SMA: | 67.78 | Buy |
| 8-day EMA: | 69.46 | Sell |
| 20-day EMA: | 70.12 | Sell |
| 50-day EMA: | 70.28 | Sell |
| 200-day EMA: | 67.67 | Buy |
Tekla Healthcare Opportunities Fund Earnings Growth & THQ Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
iShares US Pharmaceuticals ETF Earnings Growth & IHE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Tekla Healthcare Opportunities Fund Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
iShares US Pharmaceuticals ETF Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||